Physician profile
Christiane Silver
NPI 1861819492
$4,146.87
in general payments reported to CMS, 2019-2025
17 companies · $3,415 in 2025
The $3,415 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $732 · 2025: $3,415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,146.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $963.96 | 2024-2025 | Rezdiffra, Resmetirom |
| Takeda Pharmaceuticals U.S.A., INC. | $735.76 | 2024-2025 | Entyvio, Vpriv, Gattex |
| Abbvie INC. | $638.88 | 2024-2025 | |
| Janssen Biotech, INC. | $325.29 | 2024-2025 | Tremfya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $264.39 | 2024-2025 | Xifaxan, Relistor, Trulance |
| Gilead Sciences, INC. | $235.49 | 2025 | |
| Ardelyx, INC. | $228.70 | 2024-2025 | Ibsrela |
| Aimmune Therapeutics, INC. | $197.30 | 2025 | Vowst, Zenpep |
| Genzyme Corporation | $142.59 | 2024 | |
| Exact Sciences Corporation | $124.92 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $76.82 | 2024 | |
| Intercept Pharmaceuticals, INC. | $63.43 | 2024-2025 | |
| Novo Nordisk INC | $47.65 | 2025 | Wegovy, Saxenda |
| Qol Medical, LLC | $33.77 | 2024 | Sucraid |
| Regeneron Healthcare Solutions, INC. | $30.79 | 2025 | Dupixent |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $20.91 | 2025 | Omvoh |
| Phathom Pharmaceuticals, INC. | $16.22 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christiane Silver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.